Does EPTINEZUMAB-JJMR Cause Neoplasm malignant? 5 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Neoplasm malignant have been filed in association with EPTINEZUMAB-JJMR. This represents 0.1% of all adverse event reports for EPTINEZUMAB-JJMR.
5
Reports of Neoplasm malignant with EPTINEZUMAB-JJMR
0.1%
of all EPTINEZUMAB-JJMR reports
0
Deaths
1
Hospitalizations
How Dangerous Is Neoplasm malignant From EPTINEZUMAB-JJMR?
Of the 5 reports, 1 (20.0%) required hospitalization.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EPTINEZUMAB-JJMR. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does EPTINEZUMAB-JJMR Cause?
Drug ineffective (1,779)
Migraine (1,235)
Headache (821)
Therapeutic response shortened (449)
Nausea (435)
Fatigue (413)
Drug effect less than expected (298)
Throat irritation (290)
Dizziness (279)
Pruritus (245)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which EPTINEZUMAB-JJMR Alternatives Have Lower Neoplasm malignant Risk?
EPTINEZUMAB-JJMR vs EPTINEZUMAB\EPTINEZUMAB-JJMR
EPTINEZUMAB-JJMR vs EQUINE THYMOCYTE IMMUNE GLOBULIN
EPTINEZUMAB-JJMR vs ERAVACYCLINE
EPTINEZUMAB-JJMR vs ERBITUX
EPTINEZUMAB-JJMR vs ERDAFITINIB